166 related articles for article (PubMed ID: 6370860)
1. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.
Yeung MK; Mattingly SJ
Infect Immun; 1984 May; 44(2):217-21. PubMed ID: 6370860
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.
Durham DL; Mattingly SJ; Doran TI; Milligan TW; Straus DC
Infect Immun; 1981 Nov; 34(2):448-54. PubMed ID: 7030959
[TBL] [Abstract][Full Text] [Related]
3. Virulence of strains of new types and type candidates of group B streptococci (Streptococcus agalactiae). Comparative evaluation using mice and a chicken embryo model.
Wagner M; Kaatz M
Adv Exp Med Biol; 1997; 418():819-21. PubMed ID: 9331778
[No Abstract] [Full Text] [Related]
4. Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.
Yeung MK; Mattingly SJ
Infect Immun; 1983 Oct; 42(1):141-51. PubMed ID: 6352490
[TBL] [Abstract][Full Text] [Related]
5. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae.
Seifert KN; Adderson EE; Whiting AA; Bohnsack JF; Crowley PJ; Brady LJ
Microbiology (Reading); 2006 Apr; 152(Pt 4):1029-1040. PubMed ID: 16549667
[TBL] [Abstract][Full Text] [Related]
6. Group B streptococcal C protein-associated antigens: association with neonatal sepsis.
Chun CS; Brady LJ; Boyle MD; Dillon HC; Ayoub EM
J Infect Dis; 1991 Apr; 163(4):786-91. PubMed ID: 2010631
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing release of type III antigens by group B streptococci.
Doran TI; Straus DC; Mattingly SJ
Infect Immun; 1981 Feb; 31(2):615-23. PubMed ID: 7012015
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the influenza A virus on the sensitivity of mice to infection caused by Streptococcus group B].
Bulgakova TN; Grabovskaia KB; Zueva OP
Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):23-9. PubMed ID: 3318226
[TBL] [Abstract][Full Text] [Related]
9. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae.
Adderson EE; Takahashi S; Wang Y; Armstrong J; Miller DV; Bohnsack JF
Infect Immun; 2003 Dec; 71(12):6857-63. PubMed ID: 14638773
[TBL] [Abstract][Full Text] [Related]
10. Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.
Doran TI; Mattingly SJ
Infect Immun; 1982 Jun; 36(3):1115-22. PubMed ID: 7047392
[TBL] [Abstract][Full Text] [Related]
11. Strain differences in virulence of group B streptococci.
Santos JI; Shigeoka AO; Hill HR
Pediatr Res; 1982 May; 16(5):347-50. PubMed ID: 7048229
[No Abstract] [Full Text] [Related]
12. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.
Mancuso G; Tomasello F; von Hunolstein C; Orefici G; Teti G
Infect Immun; 1994 Jul; 62(7):2748-53. PubMed ID: 8005664
[TBL] [Abstract][Full Text] [Related]
13. In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.
Maurer JJ; Mattingly SJ
J Clin Microbiol; 1988 Apr; 26(4):686-91. PubMed ID: 3284898
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic factors in group B streptococci types IV and V.
Orefici G; Molinari A; Von Hunolstein C; Donelli G; Paradisi S; Recchia S; Arancia G
Chemioterapia; 1987 Jun; 6(2 Suppl):19-21. PubMed ID: 3334555
[No Abstract] [Full Text] [Related]
16. [Biological properties of Streptococcus group B: the interrelations of the virulence in mice, the adhesion to human epithelial cells and the production of type-specific antigen].
Bulgakova TN; Grabovskaia KB; Ryc M; Jelinková J; Motlová J
Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):29-34. PubMed ID: 2469270
[TBL] [Abstract][Full Text] [Related]
17. Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.
Palacios GC; Eskew EK; Solorzano F; Mattingly SJ
J Clin Microbiol; 1997 Nov; 35(11):2923-6. PubMed ID: 9350760
[TBL] [Abstract][Full Text] [Related]
18. Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.
Klegerman ME; Boyer KM; Papierniak CK; Levine L; Gotoff SP
Infect Immun; 1984 Apr; 44(1):124-9. PubMed ID: 6423540
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of an avirulent strain that induces protective immunity against challenge with virulent Streptococcus suis serotype 2.
Wang J; Feng Y; Wang C; Zheng F; Hassan B; Zhi L; Li W; Yao Y; He E; Jiang S; Tang J
BMC Microbiol; 2017 Mar; 17(1):67. PubMed ID: 28292261
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.
Shigeoka AO; Rote NS; Santos JI; Hill HR
J Infect Dis; 1983 May; 147(5):857-63. PubMed ID: 6341485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
